Table 7.
Logistic regression analysis for ischemic cardiovascular adverse events
| Variables | B (SE) | Sig. | OR (Exp[B]) | 95% CI for OR (Exp[B]) | |
|---|---|---|---|---|---|
| Lower | Upper | ||||
| CYP2C19*2 | 0.094 (0.368) | 0.798 | 1.099 | 0.534 | 2.262 |
| CYP2C19*3 | 2.147 (1.078) | 0.046 | 8.562 | 1.035 | 70.823 |
| ABCB1 3435CT | −0.677 (0.396) | 0.087 | 0.508 | 0.234 | 1.103 |
| HPR | 1.977 (0.659) | 0.003 | 7.220 | 1.983 | 26.293 |
CYP2C19: cytochrome P450 family 2 subfamily C member 19; CYP2C19*2: rs4244285; CYP2C19*3: rs4986893; ABCB1: ATP binding cassette subfamily B member 1; ABCB1 3435CT: rs1045642. Bold values Sig. 0.046 and 0.003 mean that CYP2C19*3 as well as post‐PCI HPR could function as independent predictive factors of ischemic cardiovascular adverse events.